Organization
Sapporo Med Center NTT EC, Sapporo, Japan
1 abstract
Abstract
52-WEEK RESULTS OF CLINICAL, RADIOGRAPHIC AND PHARMACOKINETIC ASSESSMENTS: GOLIMUMAB, A HUMAN ANTI-TNF MONOCLONAL ANTIBODY, ADMINISTERED SUBCUTANEOUSLY EVERY FOUR WEEKS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY Org: University of Occupational and Environmental Health, Kitakyushu, Japan, Tokyo Medical and Dental University, Keio University School of Medicine, Tokyo Women's Medical U, Tokyo, Nagoya U, Aichi,